No Data
Two Sessions Time | National People's Congress Representative, Lu Qingguo from Chenguang Biotech Group: Improve the quality standards of Chinese Patent Medicine, regulate the centralized procurement model for Traditional Chinese Medicine, and optimize the
① Lu Qingguo, Director of Chenguang Biotech Group and a representative of the National People's Congress, focused on several recommendations at this year's Two Sessions, including optimizing the procurement mechanism for Traditional Chinese Medicine, enhancing the quality standards for Chinese Patent Medicine, and standardizing the Traditional Chinese Medicine granule industry; ② In addition to recommendations related to the Traditional Chinese Medicine industry, Lu Qingguo prepared several suggestions on rural social retirement insurance, rural medical insurance, and increasing support for companies sanctioned by the United States.
MEDICSKIN intends to lease a property in Hong Kong to use as one of the group's medical skin care centers in Hong Kong.
MEDICSKIN (08307) announced that on February 7, 2025, the tenant (an indirect wholly-owned subsidiary of the company) entered into a lease agreement with the landlord (an independent third party) for the renewal of the rental property, to be used as one of the Group's medical skincare centers in Hong Kong, from February 23, 2025, to February 22, 2028 (including the start and end dates). It is reported that the property is located on the entire 21st floor of Shanghai New World Building, 18 Queen's Road Central, Hong Kong. The Group has been leasing this property since February 23, 2016, as one of its two medical skincare centers in Hong Kong.
New World: New World 2024 Annual Results Advance Announcement
New World 2024 Annual Results Advance Announcement
Shanghai New World (600628.SH): Net profit for the year 2024 is projected to increase by 113% to 161%.
Gelonghui January 16th丨Shanghai New World (600628.SH) announced a performance forecast increase for the year 2024. According to the preliminary calculations by the financial department, it is expected to achieve a net income attributable to the shareholders of the listed company of 67.5 million yuan to 82.5 million yuan, an increase of 113% to 161% year-on-year. It is expected that the net income attributable to the shareholders of the listed company, excluding non-recurring gains and losses, will be 36 million yuan to 44 million yuan, a year-on-year increase of 122% to 172%. In 2024, influenced by various consumer stimulus policies, the company's retail trade, pharmaceutical sales, hotel services, and other industries will be positively impacted.
Shanghai New World Co., Ltd (SHSE:600628) Stock Is Going Strong But Fundamentals Look Uncertain: What Lies Ahead ?
Shanghai New World Co., Ltd (SHSE:600628) Stock Is Going Strong But Fundamentals Look Uncertain: What Lies Ahead ?